These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Aprindine-induced hepatic granulomata. Elisaf M; Stefanaki-Nikou S; Voulgarelis M; Masalas C; Tsianos EV J Hepatol; 1992 Mar; 14(2-3):276-9. PubMed ID: 1500691 [TBL] [Abstract][Full Text] [Related]
67. Development of granulomatous hepatitis during treatment with interferon-alpha 2b. Propst A; Propst T; Dietze O; Kathrein H; Judmeier G; Vogel W Dig Dis Sci; 1995 Oct; 40(10):2117-8. PubMed ID: 7587776 [No Abstract] [Full Text] [Related]
68. [2 cases of acute cholestasis caused by ticlopidine]. Guzzini F; Banfi L; Gomitoni A; Marchegiani C; Novati P; Mesina M; Frigerio B Recenti Prog Med; 1997 Mar; 88(3):124-7. PubMed ID: 9173469 [TBL] [Abstract][Full Text] [Related]
69. Delayed diagnosis of cholestatic drug-induced liver injury treated with corticosteroid for adrenal insufficiency secondary to miliary tuberculosis. Lee SY; Schneier A; Schiano T; Liu SJ; Machado ON Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3046-9. PubMed ID: 26367727 [TBL] [Abstract][Full Text] [Related]
70. Pyrazinamide-induced granulomatous hepatitis. Knobel B; Buyanowsky G; Dan M; Zaidel L J Clin Gastroenterol; 1997 Jun; 24(4):264-6. PubMed ID: 9252856 [TBL] [Abstract][Full Text] [Related]
71. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
72. Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis. Caruso A; Vecchio R; Patti F; Neri S Clin Ther; 2009 Mar; 31(3):580-4. PubMed ID: 19393848 [TBL] [Abstract][Full Text] [Related]
74. Hepatic granulomas in leprosy. Their relation to bacteremia. Chen TS; Drutz DJ; Whelan GE Arch Pathol Lab Med; 1976 Apr; 100(4):182-5. PubMed ID: 786214 [TBL] [Abstract][Full Text] [Related]
75. [Clinical and morphological findings on 2 cases of icterus induced by butazolidines]. Coltorti M; Cuccurullo L; Del Vecchio-Blanco C Policlinico Prat; 1970 Mar; 77(10):309-24. PubMed ID: 5436754 [No Abstract] [Full Text] [Related]
76. Acute cholestatic hepatitis after exposure to isoflurane. Malnick SD; Mahlab K; Borchardt J; Sokolowski N; Attali M Ann Pharmacother; 2002 Feb; 36(2):261-3. PubMed ID: 11847945 [TBL] [Abstract][Full Text] [Related]
77. Fixed drug eruption to oxyphenbutazone and phenylbutazone. Nayyar KC; Pasricha JS Dermatologica; 1972; 144(4):214-6. PubMed ID: 5076722 [No Abstract] [Full Text] [Related]
78. [Rules for the histological evaluation of drug-induced liver lesions]. Bianchi L; De Groote J; Desmet V; Gedigk P; Korb G; Popper H; Poulsen H; Scheuer PJ; Schmid M; Thaler H; Wepler W Dtsch Med Wochenschr; 1975 Aug; 100(35):1746-50. PubMed ID: 1157673 [No Abstract] [Full Text] [Related]
79. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
80. Outcome and prognostic markers in severe drug-induced liver disease. Björnsson E; Olsson R Hepatology; 2005 Aug; 42(2):481-9. PubMed ID: 16025496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]